Pneumocystis carinii are coated by abundant surface proteins, named MSGs for major surface glycoproteins, that undergo antigenic variation. There are many MSG genes on the chromosomes but the MSG expression site is restricted to a unique site called type-I UCS, and silent MSG genes can be translocated to the expression site by DNA recombination. We have reported previously the existence of alternative UCS elements named type-II UCS by MSG transcript analyses (J. Infect. Dis., 171, 1563Dis., 171, -1568Dis., 171, [1995). In this study we characterized the features of type-II UCS and MSG genes that are under the control of type-II UCS (hence designated the type-II MSG family) by cDNA and genomic analyses. Contrary to type-I UCS, type-II UCS elements are located at most of the P. carinii chromosomes and are directly attached to type-II MSG genes. Type-II MSG genes consist of two subtypes in coding sizes of 2.3 kb and 3.3 kb. Antibody raised against the synthetic type-II UCS polypeptide detected products in molecular masses ranging from 90 to 100 kDa. Although the cloned type-II MSG sequences are significantly diverse, cysteine residues that are rich and highly conservative in type-I MSGs are also strictly conserved in type-II MSG proteins, showing the importance of multiple cysteines in the structural integrity of MSGs in the cell surface of P. carinii.
Introduction
sive immunization with an anti-MSG monoclonal antibody against the progression of P. carinii pneumonia, 9 Pneumocystis carinii is an opportunistic pathogen the attachment of the organism via interaction between that often causes fatal pneumonia in patients under im-MSGs and fibronectin on alveolar epithelial cells and munosuppressed or immuno-deficient conditions such as macrophages, 10 -11 a specific T-cell response to MSGs af-AIDS, cancer chemotherapy or organ transplantation. 1 t er immunization and natural infection 12 and the uptake P. carinii are coated by abundant surface proteins of o f p . carinii by alveolar macrophages mediated by the great interest to investigators. The major protein com-m a n n o s e receptor that targets the mannose moiety of ponents of both cysts and trophozoites are proteins MSG. 13 called MSG (for major surface glycoprotein;
1 " 4 previGenes encoding MSGs are repeated, highly polyously called P115, 5 gpl20 6 or gpA 7 -8 ) with an apparent mO rphic, and distributed among all of the 14-15 molecular mass ranging from 95 to 140 kDa, depend-chromosomes.
1 " 3 -7 ' 8 ' 14 " 17 We have shown previously that ing on host species, degree of glycosylation, and isolation MSG-cDNAs contain two distinct types of upstream conprocedures. MSGs are thought to play a crucial role in se rved sequences, referred to as type-I UCS and typethe host-parasite interaction during P. carinii pneumo-n UCS, in their 5' termini. Type-I UCS is involved in nia because of the partial protection conferred by pas-the control of MSG gene expression. 18 The type-I UCS Communicated by Mituru Takanami element maps to a single chromosome of about 500 kb * To whom correspondence should be addressed. Tel. +81-3-at the telomeric region, 19 is attached to expressed MSG 5449-5307, Fax. +81-3-5449-5415, E-mail: nak@ims.u-tokyo. genes. The type-I UCS is not highly repeated, but P. ac ,' JP ' , , , carinii populations contain many different MSG genes t I h e nucleotide sequence data reported in this paper will ap-T T/-in I pear in the GSDB, DDBJ, EMBL and NCBI nucleotide se-attached to the type-I UCS, suggesting that the genetic quence databases with the accession numbers AB028489 and heterogeneity of MSGs is generated by type-I UCS-MSG AB028490. recombination. [Vol. 6, Previous Northern blot analysis has shown that transcripts containing type-I UCS were major, while those containing type-II UCS were minor. 18 Biological meaning of type-II UCS transcripts as well as their expression mechanisms are not known. In this study, we characterized the type-II UCS, MSG genes under the control of type-II UCS and their genomic structures. Here we refer to the MSG gene families that are under the control of type-I and type-II UCS elements as type-I MSG and type-II MSG families, respectively. In previous reports, we and others used 'UCS' for the major type-I UCS, but here we need to discriminate these two UCS elements in the literature.
Materials and Methods

Organisms
Pathogen-free athymic (rnu/rnu) nude rats were infected with P. carinii as described, 5 and P. carinii organisms were prepared from bronchoalveolar lavage as described. 5 ' 18 The purity of P. carinii organisms as assessed by the relative intensity of ribosomal RNA bands after agarose gel electrophoresis was about 95%.
5 ' 18 
Cloning and PCR analysis
RNA and genomic DNA were prepared from P. carinii organisms as described previously. and tailed by terminal deoxynucleotide transferase with either dATP or dCTP. 5'-Ends of MSG cDNAs were amplified with either of anchor primers, (5'-GAGGATCCGGGTACCATTTTTTTTTTTTTTTTT-T-3') or (5'-CUACUACUACUAGGCCACGCTCGAC-TAGTACGGGIIGGGIIGGGIIG-3') and MSG-specific amplification primer (complimentary to positions 651-668 of MSG5 cDNA 14 ) , and the amplified fragments were cloned into pUC118. The genomic DNA was cleaved by BamHl restriction enzyme and ligated to A EMBL3 cleaved with BamHI and packaged to construct P. carinii genomic library. Type-II MSG clones were screened from the genomic library by plaque hybridization using the polymorphic MSG sequence probe or the type-II UCS probe (positions 7-204 of MSG A12 clone). The MSG 110 sequence was cloned by polymerase chain reaction (PCR) from the P. carinii genomic DNA using primers P69 (5'-CCTACTTATGGCAATCAA-3') and P70 (5'-CATCCCCATAACAATCAC-3'). The positive fragments were recloned into pUC118, sequenced and analyzed using the GCG software program (Wisconsin Package Version 9.1, Genetics Computer Group, Madison, Wise).
Karyotype blot analysis
P. carinii chromosomal DNAs were separated by pulsed field gel electrophoresis and blotted onto a membrane as described previously. 18 The membrane was probed with a type-II UCS-specific probe (positions of 7-204 of MSG clone A12) and type-I UCS probe (positions of 28-382 of MSG clone A24; DDBJ/EMBL/GenBank accession no D31918) and detected with an ECL system (Amersham, Buckinghamshire, UK).
2.4-Antibody
Anti-type-II-MSG rabbit antibody was raised against synthetic polypeptide STHLKTRDSQESAC (Fig. 4) encoded in the type-II UCS sequence, and was purified by affinity chromatography using the peptide-bound agarose.
Western blot analysis
P. carmu-infected rat lung homogenates and purified organisms were prepared as described previously.
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The control sample for immunoblotting with anti-type-II-MSG antibody was prepared as a recombinant type-II-UCS polypeptide (amino acid positions 20-52 of C210 clone) that was fused to glutathione S-transferase (GST) and inducible by an isopropyl-l-thio-/3-D-galactoside (IPTG) from plasmid pMW349 in Eschenchia coli. Bulk proteins were separated by SDS-polyacrylamide gel electrophoresis (PAGE), blotted onto membranes, and the blots were probed with anti-type-II-MSG antibody. They were incubated with peroxidase-conjugated anti-rabbit second antibody and detected with a ECL Western blotting system (Amersham, Buckinghamshire, UK).
Results
Type-II UCS encoded in cDNAs
The previous analysis of 5' ends of MSG-cDNAs amplified and analyzed by the 5' RACE method revealed two discrete products containing a long 5' sequence, type-I UCS, 450 bp in size and a short 5' sequence, type-II UCS, 250 bp in size. 18 Two cDNA clones, A12 and C210, that contained type-II UCS were analyzed and their sequences are shown in Fig. 1 . The data indicate that a type-II UCS sequence is shared with one of the known MSG sequences, MSG99 20 (see below; Fig. 1 ), showing that MSG99 belongs to the type-II MSG family. The type-II UCS of MSG99 contained a 42-bp intron that is absent in the cDNAs, as we have predicted (Fig. 1) . The sequence of type-II UCS has no homology with type-I UCS, although polymorphic regions connected to these UCSs are homologous. In Fig. 1 , the type-II UCS sequence was defined as the one that is distinct from type-I. It is noteworthy that the type-II UCS sequence is not completely conserved but shows significant diversity (Fig. 1). 
Genomic type-II UCS
The MSG99 sequence has been found in the MSG gene cluster cloned in A MW111. 20 The A MW111 clone contained 11370 bp of chromosomal DNA encoding three open reading frames (ORFs) in tandem, MSG99, MSG100 and ORF-3, a structural gene for the surface subtilisin-like protease. 20 The type-II UCS sequence preceding MSG99 is incomplete in Fig. 1 because of the cloning procedure. Downstream of this gene cluster, at the terminus of the cloned segment, there was another type-II UCS sequence (see DDBJ/EMBL/GenBank accession no. D31909). 20 This finding suggested that type-II UCS elements, hence type-II MSG genes, may be multiple genes encoded in the P. carinii chromosome(s), and that the cloned segment of A MW111 represents one of these loci.
In karyotype hybridization analysis of P. carinii chromosomes, the type-II UCS probe detected type-II UCS signals in more than 10 out of 14 to 15 chromosomes (Fig. 2, lane 1) , which is in sharp contrast to type-I UCS that hybridized uniquely with a single 500-kb chromosome (Fig. 2, lane 2) . These results indicated that the type-II MSG family consists of multiple genes and that the type-II UCS element seems to be attached to every MSG repertoire, unlike the type-I UCS element. 
Type-II MSG variants
The MSG99 sequence contained a 1-kb deletion within its C-terminal region compared with the known MSG sequences (see below; Fig. 4 ). We examined whether this deletion is common to most, if not all, of the type-II MSG genes by PCR. The type-II-MSG-specific primer set (see Fig. 3B ) amplified two distinct segments in sizes of 2 kb and 3 kb; the former products were major while [ the latter products were minor (Fig. 3A, lanes 3 and 4) . On the other hand, type-I-MSG primer sets designed for both active and silent MSG genes (Fig. 3B ) amplified only 3-kb products (Fig. 3A, lanes 1, 2, 5 , and 6). These results indicate that the type-II MSG family consists of two subtypes with different sizes, presumably due to the presence or absence of the 1-kb deletion within the C-terminal region as found in MSG99. Type-II MSG clones showing the two distinct sizes were isolated from the genomic library, and their sequences were analyzed (Fig. 4) . One of the cloned type-II MSGs, MSG110, had a 2.3-kb coding sequence containing a 1-kb C-terminal deletion similar to the one in MSG99, while the other, MSG109, had a 3.3-kb sequence without any deletion. Two 2.3-kb type-II MSG clones, MSG99 and MSG 110, are 91% homologous in nucleotide sequences and their amino acid sequences are 86% homologous (Table 1) , which is equivalent to the similarity within the type-I MSG sequences so far identified. On the other hand, MSG109, a 3.3-kb type-II MSG clone, shows 69% similarity to MSG105, a type-I MSG clone, 14 and 47-49% similarity to 2.3-kb type-II MSGs. Thus, the 3.3-kb type-II MSG is homologous to the type-I MSG rather than to the 2.3-kb type-II MSGs. Among 14 type-II MSG cDNA clones isolated, 10 clones showed higher homology to 2.3-kb type-II MSG, while 4 clones to MSG 109 (data not shown). Contrary to the MSG coding sequences, the N-terminal polypeptides encoded by type-I and type-II UCS elements are completely distinct in their sequences and sizes as shown in Fig. 4 .
3.4-De novo expression of type-II MSG
To examine the expression of type-II MSG genes in P. carinii, rabbit antibody was raised against the synthetic 12-mer polypeptide encoded by type-II UCS (see Mate- 64.
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11 Entries below the diagonal refer to the similarity percentages of amino acid residues. Entries above the diagonal refer to the percentages of identical nucleotide residues. rials and Methods). The antibody reacted, as expected, with the recombinant type-II UCS protein fused to GST but not with GST alone (Fig. 5, lanes 4 and 5) . Western blot analyses of lung homogenates derived from P. carinii-infected rats (Fig. 5, lanes 1 and 2) or purified P. carinii isolates (Fig. 5, lane 3) revealed one or two bands in sizes ranging from 90 to 100 kDa, whose patterns varied depending on the preparations. Compared with the product size of type-I MSG (i.e., ~ 115 kDa), multiple bands detected by anti-type-II-UCS antibody might be caused by protein modifications rather than due to respective MSG products of the 2.3-and 3.3-kb type-II subtypes. It could not be excluded that some type-II MSG products were not detected by this antibody against the synthetic polypeptide. These observations led us to conclude that the type-II MSG genes are expressed in P. carinii; hence, type-II UCS seems to be sufficient to initiate transcript synthesis and protein secretion. 
Discussion
In this study, we confirmed the existence of an alternative UCS element, called type-II UCS, that was originally discovered by our analysis of MSG-cDNA collections, 18 and extended further the genomic structure of type-II UCS as well as type-II-preceding MSG genes referred to as type-II MSG. Contrary to type-I UCS, type-II UCS elements are spread to most, if not all, of the 14 to 15 chromosomes of P. carinii (Fig. 2 ) and seem to function as multiple expression sites. Several lines of evidence predict that type-II MSG does not involve DNA rearrangement for expression. First, every type-II UCS encodes a signal sequence, directly precedes type-II MSG genes in the genome, and is ready for expression without any DNA rearrangement. Second, type-II UCS has no specific sequence called CRJE, referred to conserved recombination junction element, that has been proposed for the putative site-specific recombination element 18 (Fig. 6) . Therefore, [Vol. 6, the expression of the type-II MSG family seems to be regulated differently from that of the type-I MSG family. In spite of the sequence variation in type-I and type-II MSG polypeptides, cysteine residues are rich in both type-I and type-II MSG proteins and are strictly conserved at equivalent positions (Fig. 6) . It has been already pointed out that type-I MSG proteins contain nearly 60 conservative cysteines 14 and these residues may be involved in complexed structural formation by intraor inter-polypeptide disulfide bonds on the dense cell walls of P. carinii. 1 An extremely high conservation of cysteine residues was also found among the organisms from other animals such as mice, ferrets, rhesus monkeys and humans. 15 ' 21 Interestingly, the C-terminal deletion of the type-II MSG subfamily occurred at the region that was poor in cysteine (Fig. 6) . Therefore, given that cysteines are important for the structural complexity of the P. carinii cell surface, the deletion seemed to take place not to impair the structural integrity. One can speculate that the occurrence of intra-or inter-polypeptide disulfide bond formation may create or link the repetitive secondary structure on the P. carinii cell surface, which may be functionally important in the host-organism interaction, immune response or other pathobiological activities of P. carinii.
There is a potential GPI (for glycosyl phosphatidylinositol) anchorage motif in the C-terminal region of MSGs.
1 ' 22 GPI anchors are known to play an important role in the attachment of surface proteins to cell glycans in many mammalian cells as well as in some parasites for surface antigenic variation. 23 ' 24 Recently, it has been reported that the GPI anchor is used for MSG expression on the cell surface. 25 Nevertheless, in the case of the short type-II MSG subtype, the 1-kb C-terminal deletion seemed to affect the potential attachment site for the GPI anchor. Therefore, we assume that this class of MSGs may be anchored by the C-terminal hydrophobic tail 14 but not through GPI. Since P. carinii has mainly two life stages, cyst and trophozoite, that are very different in terms of cell wall structures, it remains to be investigated if two distinct MSG families are involved differentially in P. carinii life stages.
Three MSG genomic clones, MSG99, MSG109 and MSG110, possess very different N-glycosylation possibility both in numbers and positions; 4 sites for MSG99, 10 for MSG109 and 2 for MSG110, which may influence the apparent heterogeneity of MSGs.
Following near completion of this work, we became aware of recent studies that warrant mention. Huang et al. 26 and Schaffzin et al. 27 have also confirmed the existence of genomic sequences equivalent to type-II UCS. The basic features between type-II MSG (present study) and their counterpart sequences are very similar. According to the report, 26 the sequence similarity between two type-II MSG subtypes is higher than that between type-I MSG and type-II MSG, unlike the present observation. These notions were interpreted as indicating potentially high sequence variations in the type-II MSG polypeptides. Regulation of expression of type-II-MSG genes and their functions in P. carinii development and pathogenesis remain to be investigated.
